Payer Intervention and Biosimilar Switching
Experts Bruce A. Feinberg, DO; Marcus H. Snow, MD; and Hope S. Rugo, MD, discuss insurance coverage for biosimilar products and consider the effects of switching therapy in rheumatology versus oncology.
October 11, 2017
View Text Version